E

veryone loves a winner, but who are they? Let us help you figure it out. Each Friday, we will provide a quick rundown of individuals or companies that accomplished something worth noting. But to be fair, we will also point out those who, well, had a rough time. And if you have a nomination, send us a note. We would not want anyone to feel left out, even the losers.

Winners

Pharma CEOs: Amid political upheaval, pricing uncertainty, and public backlash, it still pays to be a pharma chief. AstraZeneca CEO Pascal Soriot made $16.3 million in total compensation last year, a 68 percent jump over his 2015 haul. Richard Gonzalez, CEO of AbbVie, brought in $21 million, while the leaders of Novartis and Roche each made about $12 million. In the next few weeks, we’ll learn how much the CEOs of Regeneron, Johnson & Johnson, and Allergan took home in 2016, too. Expect a great many zeros.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for Morning Rounds

A daily dose of health and medicine news — and a finalist for Digiday’s best email newsletter.

Recommended Stories